Literature DB >> 17118223

An update on autonomic neuropathy affecting the gastrointestinal tract.

Liza K Phillips, Christopher K Rayner, Karen L Jones, Michael Horowitz.   

Abstract

Gastrointestinal symptoms and disordered gut motility occur frequently in the diabetic population and are generally regarded as manifestations of gastrointestinal "autonomic dysfunction," although the relationships between both symptoms and dysmotility with abnormal cardiovascular autonomic function are weak. It is now recognized that the blood glucose concentration is both a determinant of and determined by gastrointestinal function. An improved definition of the underlying pathophysiology should facilitate the development of therapies that are targeted more effectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118223     DOI: 10.1007/s11892-006-0073-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  52 in total

1.  Botulinum toxin for the treatment of gastroparesis: a preliminary report.

Authors:  Brian E Lacy; Estephan N Zayat; Michael D Crowell; Marvin M Schuster
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

2.  Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus.

Authors:  E Schvarcz; M Palmér; J Aman; M Horowitz; M Stridsberg; C Berne
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

3.  Acute effects of C-peptide on gastric emptying in longstanding type 1 diabetes.

Authors:  Julie E Stevens; Antonietta Russo; Carol A Delaney; Peter J Collins; Michael Horowitz; Karen L Jones
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

Review 4.  Treatment of gastroparesis: a multidisciplinary clinical review.

Authors:  T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

5.  Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy.

Authors:  Viktoria Granberg; Niels Ejskjaer; Mark Peakman; Göran Sundkvist
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

6.  Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes.

Authors:  C L He; E E Soffer; C D Ferris; R M Walsh; J H Szurszewski; G Farrugia
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

7.  Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes.

Authors:  Antonietta Russo; Julie E Stevens; Richard Chen; Diana Gentilcore; Richard Burnet; Michael Horowitz; Karen L Jones
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

8.  Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation.

Authors:  Zhiyue Lin; Jameson Forster; Irene Sarosiek; Richard W McCallum
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis.

Authors:  C E Farup; N K Leidy; M Murray; G R Williams; L Helbers; E M Quigley
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

10.  Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.

Authors:  P Enck; W Rathmann; M Spiekermann; D Czerner; D Tschöpe; D Ziegler; G Strohmeyer; F A Gries
Journal:  Z Gastroenterol       Date:  1994-11       Impact factor: 2.000

View more
  14 in total

1.  Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology.

Authors:  Péter Kempler; Tamás Várkonyi; Anna E Körei; Viktor J Horváth
Journal:  Diabetologia       Date:  2015-12-05       Impact factor: 10.122

Review 2.  Management of chronic constipation in patients with diabetes mellitus.

Authors:  V G M Prasad; Philip Abraham
Journal:  Indian J Gastroenterol       Date:  2016-12-17

3.  Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.

Authors:  Pengmin Chen; Jingbo Zhao; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

Review 4.  Diabetes-related dysfunction of the small intestine and the colon: focus on motility.

Authors:  Viktor József Horváth; Zsuzsanna Putz; Ferenc Izbéki; Anna Erzsébet Körei; László Gerő; Csaba Lengyel; Péter Kempler; Tamás Várkonyi
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.

Authors:  Adam D Farmer; Anne Grave Pedersen; Birgitte Brock; Poul Erik Jakobsen; Jesper Karmisholt; Sahar D Mohammed; S Mark Scott; Asbjørn Mohr Drewes; Christina Brock
Journal:  Diabetologia       Date:  2017-01-20       Impact factor: 10.122

6.  Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.

Authors:  Peng-Min Chen; Hans Gregersen; Jing-Bo Zhao
Journal:  World J Diabetes       Date:  2015-05-15

7.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15

Review 8.  Cellular pathogenesis of diabetic gastroenteropathy.

Authors:  T Ordög; Y Hayashi; S J Gibbons
Journal:  Minerva Gastroenterol Dietol       Date:  2009-09

Review 9.  Strategies to Refine Gastric Stimulation and Pacing Protocols: Experimental and Modeling Approaches.

Authors:  Leo K Cheng; Nipuni D Nagahawatte; Recep Avci; Peng Du; Zhongming Liu; Niranchan Paskaranandavadivel
Journal:  Front Neurosci       Date:  2021-04-22       Impact factor: 5.152

10.  Hepatic insulin gene therapy prevents diabetic enteropathy in STZ-treated CD-1 mice.

Authors:  Shuo You; Mallappa Anitha; Sean Md deSouza; Dingwu Jia; Xianghua Lu; Miroslaw Kozlowski; Darin E Olson; Shanthi Srinivasan; Peter M Thulé
Journal:  Mol Ther Methods Clin Dev       Date:  2015-09-02       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.